• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用迷幻剂者对迷幻剂政策和实践的偏好和支持。

Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics.

机构信息

Population Studies Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.

Anesthesiology Department and Chronic Pain and Fatigue Research Center, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

J Psychoactive Drugs. 2023 Nov-Dec;55(5):650-659. doi: 10.1080/02791072.2023.2228784. Epub 2023 Jun 23.

DOI:10.1080/02791072.2023.2228784
PMID:37353935
Abstract

Legal, scientific, and social landscapes for psychedelics are changing rapidly. Differences of opinion exist among key stakeholders regarding regulatory control, models of provisioning psychedelic therapy, and medicalization, decriminalization, and/or legalization policies. We assessed the policy preferences of people using psychedelics naturalistically ( = 1221) to understand how they aligned and differed with institutional entities and existing psychedelic policies. Three quarters of participants would support decriminalization and legalization. On average, participants strongly supported individuals being legally able to grow and possess psychedelic plants and/or fungi for personal consumption. Trends included more support for natural over synthetic substances, self-production and consumption over gifting, gifting over sales, and administration of psychedelics with therapeutic support than without therapeutic support. Participants were concerned about pharmaceutical-like policy models, including patents of natural and synthetic psychedelic compounds. Participants were mostly from the State of Michigan, though geographical differences were minor. Those who identified as a psychedelic guide, educator, or therapist had small yet extensive differences from those who did not. As psychedelic liberalization continues to advance, it is critical for policymakers to consider these preferences to ensure laws provide safe and equitable access to these substances and appropriate medical support for their use.

摘要

迷幻药的法律、科学和社会环境正在迅速变化。在监管控制、迷幻药治疗供应模式以及医学化、非刑罪化和/或合法化政策方面,主要利益相关者之间存在意见分歧。我们评估了自然使用迷幻药的人的政策偏好(=1221),以了解他们如何与机构实体和现有的迷幻药政策保持一致和不同。四分之三的参与者将支持非刑罪化和合法化。平均而言,参与者强烈支持个人合法地种植和拥有迷幻植物和/或真菌供个人消费。趋势包括对天然物质而非合成物质、自我生产和消费而非馈赠、馈赠而非销售、以及在有治疗支持的情况下而非没有治疗支持的情况下使用迷幻药的支持度更高。参与者担心类似药物的政策模式,包括天然和合成迷幻化合物的专利。参与者主要来自密歇根州,但地域差异很小。那些自认为是迷幻药指导者、教育者或治疗师的人,与那些没有自认为是迷幻药指导者、教育者或治疗师的人相比,差异虽小但却很广泛。随着迷幻药的自由化继续推进,政策制定者必须考虑这些偏好,以确保法律为这些物质提供安全和公平的获取途径,并为其使用提供适当的医疗支持。

相似文献

1
Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics.使用迷幻剂者对迷幻剂政策和实践的偏好和支持。
J Psychoactive Drugs. 2023 Nov-Dec;55(5):650-659. doi: 10.1080/02791072.2023.2228784. Epub 2023 Jun 23.
2
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.美国的大麻和迷幻药立法及微量用药兴趣状况。
JAMA Health Forum. 2024 Jun 7;5(6):e241653. doi: 10.1001/jamahealthforum.2024.1653.
3
Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.评论:实现常见迷幻药物允许剂量近似均等的循证推荐。
J Psychoactive Drugs. 2024 Apr-Jun;56(2):206-210. doi: 10.1080/02791072.2023.2201244. Epub 2023 Apr 16.
4
Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.我们是否应该对利里(Leary)持怀疑态度?对迷幻药研究人员使用迷幻药的担忧。
J Psychopharmacol. 2023 Jan;37(1):45-48. doi: 10.1177/02698811221133461. Epub 2022 Nov 15.
5
An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically.对自然使用迷幻剂人群的迷幻剂知识评估。
J Psychoactive Drugs. 2023 Sep-Oct;55(4):420-424. doi: 10.1080/02791072.2022.2142709. Epub 2022 Nov 3.
6
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry.精神科中使用迷幻剂的伦理和实践考虑。
Psychiatr Serv. 2023 Aug 1;74(8):838-846. doi: 10.1176/appi.ps.20220525. Epub 2023 Mar 29.
7
Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia.澳大利亚潜在心理健康服务使用者和普通民众对迷幻药物和迷幻药物辅助治疗的态度。
Aust N Z J Psychiatry. 2024 Oct;58(10):904-913. doi: 10.1177/00048674241261779. Epub 2024 Jun 22.
8
Psychedelic Drug Legislative Reform and Legalization in the US.美国迷幻药立法改革与合法化。
JAMA Psychiatry. 2023 Jan 1;80(1):77-83. doi: 10.1001/jamapsychiatry.2022.4101.
9
Manifest your desires: Psychedelics and the self-help industry.显化你的欲望:迷幻药与自助行业。
Int J Drug Policy. 2022 Jul;105:103704. doi: 10.1016/j.drugpo.2022.103704. Epub 2022 May 8.
10
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.迷幻剂:治疗情绪和焦虑障碍的替代和潜在治疗选择。
Molecules. 2022 Apr 14;27(8):2520. doi: 10.3390/molecules27082520.

引用本文的文献

1
State Cannabis and Psychedelic Legislation and Microdosing Interest in the US.美国的大麻和迷幻药立法及微量用药兴趣状况。
JAMA Health Forum. 2024 Jun 7;5(6):e241653. doi: 10.1001/jamahealthforum.2024.1653.